Careteq Ltd. AI Stock Analysis
Want to see AU:CTQ full AI Analyst Report?
Careteq Ltd. (CTQ) AI Stock Analysis
Careteq Ltd.
(ASX:CTQ)
The overall score of 44 is very low, driven primarily by severe operational and cash flow weaknesses. The company is burning cash rapidly while revenues contract, which is the most significant risk. This is compounded by a bearish technical trend with the stock trading below all major moving averages. While the balance sheet is deleveraged, it does not offset the immediate threats from an unprofitable business model and negative market momentum.
Careteq Ltd. (CTQ) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 6.60M
- Dividend Yield
- ―
- Average Volume (3M)
- 1.56M
- Price to Earnings (P/E)
- -7.5
- Beta (1Y)
- 0.04
- Revenue Growth
- -20.21%
- EPS Growth
- -66.67%
- Country
- Australia
- Employees
- 686
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Careteq Ltd. Business Overview & Revenue Model
Company Description
Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company provides healthcare safety and clinical services. Careteq Limited was incorporated in 2016 and is based in Melb...
Careteq Ltd. Financial Statement Overview
Summary
Financial performance is weak. The income statement shows a sharp revenue decline and a return to operating losses, with volatile margins. The balance sheet is a relative strength after significant deleveraging, but the cash flow statement reveals persistent and worsening cash burn, which is a critical risk. The overall financial health is poor due to an unprofitable, cash-consuming core business.
Income Statement
45NeutralBalance Sheet
72PositiveCash Flow
25Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.08M | 6.08M | 7.62M | 7.23M | 4.98M | 4.43M |
| Gross Profit | 5.79M | 5.79M | 1.50M | 6.74M | -2.44M | 4.14M |
| EBITDA | 13.95K | 13.95K | 275.62K | -826.62K | -2.65M | -5.90M |
| Net Income | 246.13K | -398.12K | -72.20K | -2.67M | -4.33M | -5.25M |
Balance Sheet | ||||||
| Total Assets | 3.78M | 3.78M | 5.94M | 6.82M | 7.57M | 8.02M |
| Cash, Cash Equivalents and Short-Term Investments | 3.19M | 3.19M | 1.05M | 1.25M | 1.85M | 4.50M |
| Total Debt | 47.56K | 47.56K | 2.37M | 192.98K | 961.96K | 0 |
| Total Liabilities | 549.17K | 549.17K | 4.42M | 3.30M | 4.02M | 1.72M |
| Stockholders Equity | 3.23M | 3.23M | 1.52M | 1.97M | 2.14M | 6.30M |
Cash Flow | ||||||
| Free Cash Flow | -1.56M | -1.56M | -804.93K | -2.59M | -3.42M | -4.54M |
| Operating Cash Flow | -1.50M | -1.50M | -732.06K | -1.30M | -2.53M | -4.52M |
| Investing Cash Flow | 3.92M | 3.92M | 119.16K | -570.80K | -799.63K | -256.83K |
| Financing Cash Flow | -278.85K | -278.85K | 400.96K | 1.27M | 687.55K | 8.81M |
Careteq Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CTQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 42.74 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CTQ.
Careteq Ltd. Peers Comparison
Overall Rating
AU:ALC69Neutral
AU:ONE48Neutral
AU:BMT45Neutral
AU:CTQ44Neutral
AU:ICR37Underperform
AU:PCK37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | AUD 164.00M | 74.70 | 2.53% | ― | 26.61% | 38.21% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | AUD 113.29M | -6.36 | -203.69% | ― | -1.53% | 28.29% | |
| 45Neutral | AUD 20.08M | -1.03 | -58.13% | ― | 2.08% | -195.31% | |
| 44Neutral | AUD 6.60M | -7.50 | 11.00% | ― | -20.21% | -66.67% | |
| 37Underperform | AUD 12.16M | -5.00 | -416.53% | ― | 113.42% | 29.17% | |
| 37Underperform | AUD 14.02M | -1.47 | -1688.04% | ― | 11.45% | 0.69% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:CTQ | Careteq Ltd. | 0.01 | 0.00 | 0.00% | |
| AU:ONE | Oneview Healthcare PLC Chess Depository Interests repr 1 | 0.14 | -0.16 | -55.00% | |
| AU:BMT | Beamtree Holdings Ltd | 0.07 | -0.14 | -67.50% | |
| AU:ALC | Alcidion Group Limited | 1.27 | 0.22 | 20.95% | |
| AU:ICR | InteliCare Holdings Limited | 0.02 | -0.01 | -34.62% | |
| AU:PCK | PainChek Ltd | 0.06 | -0.31 | -82.70% |
Careteq Ltd. Corporate Events
Careteq Appoints Digital Health Executive to Advisory Board
Careteq is an Australian clinical healthtech company providing AI-enabled healthcare solutions, including its HMR Referrals marketplace for streamlining Home Medicines Reviews. The company focuses on healthcare technology and digital services designe...
Careteq Advances AI-Enabled HMR Platform as Cash Reserves Support Growth
Careteq has advanced development of its HMR Referrals platform, adding workflow tools that centralise referral intake, pharmacist allocation, appointment scheduling, report preparation and follow-up in a single environment. For GPs and practices, new...
Careteq Sets 2026 AGM, Emphasises Proxy Voting and Compliance
Careteq Limited has scheduled its 2026 Annual General Meeting for 27 November in Melbourne, with shareholders eligible to vote based on the share register as at the evening of 25 November. The company is encouraging investors to use proxy voting and...
Careteq Sets Date and Nomination Deadline for 2026 AGM
Careteq Limited has scheduled its 2026 Annual General Meeting for 10:00am AEDT on 27 November 2026, in line with ASX listing rules and its constitution. The company has also set 5:00pm AEDT on 9 October 2026 as the deadline for written nominations fr...
Careteq Lodges Form 605 Notice on Changes in Substantial Shareholding
Careteq Ltd. has released a Form 605 notice under Section 671B of the Corporations Act 2001, recording that a holder has ceased to be a substantial shareholder and detailing potential changes in relevant interests and associations in its voting secur...
Careteq Says No Undisclosed News Behind Share Price Surge
Careteq Limited, an ASX-listed provider of technology-enabled care solutions for vulnerable and elderly individuals, focuses on remote monitoring, emergency alert systems and connected-care platforms for both institutional and private customers. The...
ReNerve Outlines 2026 Governance Framework Aligned with ASX Principles
ReNerve Limited has reaffirmed its adherence to the ASX Corporate Governance Principles and Recommendations in its 2026 corporate governance statement, detailing the board’s responsibility for strategy, risk management, and shareholder accountability...
Careteq Files Updated Corporate Governance Statement with ASX
Careteq Limited has lodged its Corporate Governance Statement for the year ended 30 June 2026 with the ASX, confirming it is current as at 27 August 2026 and accessible via the company’s investor centre website. The filing complies with ASX Listing R...
Careteq Resets Balance Sheet and Doubles Down on HMR Referrals Platform
Careteq has completed a major balance sheet and strategic reset in FY26, divesting its Embedded Health Solutions business, repaying all borrowings, raising $2.2 million in new equity and converting all convertible notes into shares. The company finis...
Careteq books deeper loss as subsidiary sale reshapes balance sheet
Careteq Limited reported a 21.3% fall in revenues to $6.08 million for the year to June 30, 2026, and a sharply higher after-tax loss of $398,121, with no dividends declared. Despite the weaker operating performance, net tangible assets per share imp...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
